GlaxoSmithKline (GSK)

GAVI and US Merck Link on Ebola Vaccine

Drug Firms Urge Governments to Fight Superbugs

New Immunotherapy Coalition Launched in US

Amgen Takes Back Bone Drugs from GSK

GSK Outlines Pipeline for Next 10 Years

Drugmakers Launch UK Dementia Fund

Teva Launches Generic Dutasteride

Topics • Strategy

Leaving the Patent Cliff Behind

Topics • Strategy

Pharma Players Mostly Lift 2015 Guidance

Topics • Strategy

Allotrope Foundation Releases Allotrope Framework 1.0

EU Commissions Backs New GSK Asthma Drug

Perrigo Acquires Scar Management Brand

Novartis Buys Rights to Multiple Sclerosis Drug from GlaxoSmithKline

GSK Says Drugs from Closed Plant Safe

GSK Shutters Plant on Bacteria Concerns

Pfizer Ranked Top Foreign Firm in UK Academic Research

Glaxo Arm Signs HIV Toll Deal for China

US Sandoz Arm Fights US Overpay Lawsuit

Pfizer Speculated to Have GSK in its Sights

GSK Chief Witty Questions Pharma M&A Economics

Topics • Strategy

Drugs Industry Battered by Currency and Competition

Adaptimmune Strengthens Management Team with Key Executive Hires

Novartis Gets Green Light to Buy GSK Cancer Drugs

GSK Acquires GlycoVaxyn for $212 Million

EC Approves Novartis-GSK Asset Swap With Strings

GSK Chief Sees More Unit IPOs as Options

Germany's Merck Plans to Expand in Consumer Health

GSK Soon to Start Ebola Vaccine Trials

US Steps up Production of Experimental Ebola Drug

Bayer Closes $14.2 Billion Buy of Merck & Co OTC

Topics • Strategy

Accelerating the Benefits Achievable from Biocatalysis

China Fines GSK Nearly $500 Million on Bribery Charges

Topics • Strategy

M&A in Chemicals & Pharmaceuticals

GSK’s Ebola Vaccine Fast-tracked Into Clinical Trials

Aesica Appoints New Product Release Manager

181 more articles

Top-Feature

Evonik Industries AG

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

Capillary Electrophoresis in Biotherapeutic Development: Platform Methods, Fragment Workflows, and ADC Characterization

Global Impact Coalition (GIC)

Siemens Joins the Global Impact Coalition

Agilent Technologies Inc.

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

CHEManager International c/o Wiley-VCH GmbH

Upcoming Virtual Events

Aenova Holding GmbH

Mastering Modified Release: The Pellet-Based Approach

Operationalizing AI in Polymer Development: How Syensqo Is Scaling Impact with the Citrine Platform

From Lab to Market Challenge

Vote Now: Germany's Most Promising Chemistry Start-ups

Choose your favourite among the finalists

Vote Now: Germany's Most Promising Chemistry Start-ups

The "From Lab to Market Challenge" brings together the most promising founders from chemistry, materials science, and industrial biotechnology. Starting June 1st, you can cast your public vote for the finalists on CHEManager.com — before the award ceremony with €10,000 in prizes takes place on June 25th.

Thomson Reuters

Society of Chemical Industry (SCI)

GlaxoSmithKline (GSK) plc

Cincinnati USA Reg. Chamber

Sanofi S.A.

Microinnova Engineering GmbH

EvaluatePharma

Thermo Fisher Scientific

Novo Nordisk A/S

Novartis International AG

ISPE D/A/CH e.V.

Chemical Market Reporter

Oracle Germany

EDB Singapore